The federal contract IDV was awarded by the Department of Health and Human Services (HHS) to the Department of Health, doing business as Medicines & Healthcare Products Regulatory Agency, for the provision of other ADP and telecommunications services. The contract has a ceiling value of $1,401,965.00 and a period of performance through September 26, 2009. Under this IDV, the National Cancer Institute (NCI), a component of HHS, has issued task orders to leverage the Department of Health's...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide Biomedical Information Management and Analytic Support Services. The multiple award IDV has a potential value of $148 million over five years. Task orders issued to date include $1.56 million for data analytics, statistical analysis and bioinformatics support for genome-wide association studies under cost plus fixed fee pricing to...
The National Cancer Institute awarded a single-award, indefinite delivery contract valued up to $500 million to the Tennessee Department of Health, Division of Fiscal Services as the prime contractor. The contract supports the Surveillance Epidemiology and End Results program through the collection and management of cancer incidence, treatment, and survival data. A $49.5k firm fixed price delivery order was issued against the contract for registry linkages and data management from September 2023...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery indefinite quantity multiple award contract with a potential value of $148 million to provide biomedical information management and analytic support services. Task areas under the contract include data modeling, acquisition and management; data analysis, statistical and bioinformatics analysis and tool development; and general program support. Two task orders have been issued against this contract. The...
The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), awarded a $190 million Blanket Purchase Agreement (BPA) to Information Management Services, Inc. (IMS), a for-profit Subchapter S corporation. Under this BPA, IMS provides a wide range of biomedical computing support services to NCI, including data management, analytics, IT services, and clinical trial support. The BPA has no set-aside designation and runs through July 2020. Task orders issued...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery contract to Information Management Services, Inc. for biomedical information management and analytic support services with a potential value of $148 million. Under the contract vehicle, three task orders have been awarded to date for data infrastructure support, data management and preparation services, and advanced statistical and bioinformatics analysis for various cancer research studies. Task order...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
The National Cancer Institute Information Technology Blanket Purchase Agreement provides for critical and complex information technology services to support the scientific, business, and administrative requirements of the National Cancer Institute. Awarded to Unissant Inc., the multiple-award IDV has a potential value of $1.7 billion over five years. One task order issued against the agreement is the National Cancer Institute Information Technology Resource Center Primary Support BPA Call,...
The National Cancer Institute awarded a single-award indefinite delivery contract to the Arkansas Department of Health to support the Surveillance, Epidemiology, and End Results Program. The contract has a potential value of $500 million over an eight-year period of performance from May 2021 through April 2028. Under the contract, the prime contractor will collect and report cancer incidence, treatment, and survival data as part of SEER. Data will be managed through the SEER*DMS system and cover...
The National Cancer Institute Information Technology Blanket Purchase Agreement is a multiple award IDV issued by the National Institutes of Health National Cancer Institute. With a potential value of $1.7 billion, it provides critical and complex IT services that support the scientific, business, and administrative requirements of the NCI DOCS through Nov 2027. Essex Management LLC is the prime contractor. The BPA aims to procure a wide range of IT services without set-asides. Task orders...
This Blanket Purchase Agreement from the National Institutes of Health's National Cancer Institute provides the Department of Health, doing business as the Medicines & Healthcare Products Regulatory Agency, with licenses and services supporting cancer research. Under multiple firm fixed price calls, the contractor delivers access to the United Kingdom's Clinical Practice Research Datalink databases and linkages to other registries. A $160,000 call procures a 12-month license for National Cancer Institute investigators to access medical research datasets. Other calls valued from $12,571 to $173,100 provide linkages of clinical practice data to study reproductive cancers and hormone therapy risks. The solitation sought a 12-month license to primary care and national health databases, as well as epidemiological support services. Deliverables aid the National Cancer Institute's efforts leveraging real-world evidence through the contractor's established clinical datasets and expertise in data integration and analytics. Performance takes place in the United Kingdom, Potomac, Maryland, with the blanket purchase agreement expiring in September 2023.
The National Cancer Institute utilizes this indefinite delivery vehicle to access established United Kingdom medical datasets and expertise supporting its cancer research mission. Multiple calls procure licenses and services integrating clinical practice data toward epidemiological studies of reproductive factors and hormone therapy impacts. The contractor's established databases and linkages to other United Kingdom registries provide real-world evidence to advance the agency's understanding of cancer incidence, outcomes and risks.